PAVM — PAVmed Inc.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1624326 ·
Last close
$6.14
Market Cap
$43.96M
52W High
$10.98
52W Low
$6.00
ADV30
14,206
Next earnings
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck device. Its product pipeline also comprises EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 -60,000
Dec 2025 52,000 -33,000 -6,648,000 -1,263,000 38,812,000 1,538,000 16,512,000
Sep 2025 5,000 -50,000 -4,681,000 -5,383,000 38,069,000 3,103,000 12,282,000
Jun 2025 6,000 -35,000 -4,635,000 -11,921,000 43,893,000 4,004,000 12,474,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-5,206,000
Investing CF
$-31,000
Financing CF
$5,590,000
CapEx
$-31,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-82.20
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-258,731,000
Inventory
$239,000
Receivables
$15,000
ST Investments
EBIT TTM
$-2,448,000
Pretax Income TTM
$-2,469,000
Interest Exp TTM
$21,000
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$71,000
EBITDA
$-21,701,000
Free Cash Flow
$-13,997,875
Enterprise Value
$65,646,236
Total Cash
$1,952,000
Total Debt
$13,348,000
Shares Out
7,159,034
Trailing EPS
$-48.25
Book Value
$10.01
ROE
-32.3%
ROA
-39.2%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 71,000 -21,390,000 401,000 38,812,000 16,512,000 -5,206,000
Dec 2024 2,995,000 -44,378,000 39,791,000 30,660,000 37,693,000 -33,554,000
Dec 2023 2,452,000 -68,795,000 -64,175,000 33,119,000 57,137,000 -52,036,000
Dec 2022 377,000 -91,087,000 -88,983,000 53,980,000 43,046,000 -70,985,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-2.74

Peers — same industry

TickerNameMarket CapLastDaily %
NSPR InspireMD, Inc. $44.50M $0.95
ARAY ACCURAY INC $44.56M $0.37
PSTV PLUS THERAPEUTICS, INC. $45.43M $6.60
NTRB NutriBand Inc. $42.36M $3.48
AURX Nuo Therapeutics, Inc. $47.92M $0.99

News headlines (Yahoo Finance, 1h cache)

PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Restructuring and Growth ...
2026-05-15 23:01 · Yahoo
PAVmed (PAVM) Q4 2025 Earnings Transcript
2026-05-15 15:36 · Yahoo
PAVmed Inc. (PAVM) Reports Q1 Loss, Lags Revenue Estimates
2026-05-15 13:15 · Yahoo
PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results
2026-05-15 12:00 · Yahoo
Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Misses Revenue Estimates
2026-05-14 13:20 · Yahoo
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results
2026-05-14 12:00 · Yahoo
Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates
2026-05-13 22:40 · Yahoo
NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates
2026-05-12 21:40 · Yahoo
Will PAVmed Inc. (PAVM) Report Negative Earnings Next Week? What You Should Know
2026-05-08 14:00 · Yahoo
Alphatec (ATEC) Reports Break-Even Earnings for Q1
2026-05-05 22:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.